세계의 식도 스텐트 시장

Global Esophageal Stents Market to Reach US$122.7 Million by 2030

The global market for Esophageal Stents estimated at US$89.1 Million in the year 2024, is expected to reach US$122.7 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$81.5 Million by the end of the analysis period. Growth in the Specialty Clinics segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$23.2 Million While China is Forecast to Grow at 8.4% CAGR

The Esophageal Stents market in the U.S. is estimated at US$23.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Esophageal Stents Market - Key Trends and Drivers Summarized

What Are Esophageal Stents and Why Are They Used?

Esophageal stents are tubular devices inserted into the esophagus to maintain luminal patency in patients suffering from esophageal obstructions caused by malignant tumors, benign strictures, or other anatomical abnormalities. They play a critical role in alleviating symptoms like dysphagia (difficulty swallowing), which can severely impact a patient’s quality of life and nutritional status. Esophageal stents are typically used in cases of esophageal cancer, where the tumor obstructs the passage of food, or in benign conditions such as peptic strictures, which result from prolonged acid exposure and subsequent scar tissue formation. They can also be utilized to manage complications like tracheoesophageal fistulas or esophageal perforations, serving as a bridge to more definitive treatment or as a palliative measure to enhance the patient’s comfort. Esophageal stents are made from various materials such as nitinol, a flexible alloy that allows for self-expansion, or silicone-covered metal, which helps prevent tissue ingrowth. These stents come in both covered and uncovered variants: covered stents are designed to block tumor growth into the lumen and manage leaks, while uncovered stents provide a firmer anchorage in cases of benign strictures. Depending on the clinical scenario, stent placement can be performed endoscopically or under fluoroscopic guidance, with the aim of immediate symptomatic relief and the restoration of oral intake. As a versatile and minimally invasive solution, esophageal stents have become an essential option in managing complex esophageal conditions, offering both therapeutic and palliative benefits.

How Are Technological Advancements Improving the Functionality of Esophageal Stents?

Technological advancements have revolutionized the design and application of esophageal stents, enhancing their safety, effectiveness, and overall patient outcomes. One of the most significant developments is the introduction of fully covered self-expanding metal stents (SEMS), which provide optimal support while reducing complications such as tumor ingrowth and food impaction. The use of advanced materials like nitinol, known for its superelasticity and shape memory properties, has allowed manufacturers to create stents that conform precisely to the irregular anatomy of the esophagus, minimizing the risk of migration and maximizing patient comfort. Some stents now feature anti-reflux valves, which prevent gastroesophageal reflux-a common issue in patients with malignant strictures-thus improving their quality of life post-procedure. Innovations in coating materials, such as silicone or polyurethane, have also been pivotal, providing a smooth inner surface that reduces biofilm formation and prevents stent obstruction. Moreover, the integration of drug-eluting technology into esophageal stents is a recent breakthrough. These stents are coated with chemotherapeutic agents or anti-proliferative drugs to prevent tissue hyperplasia and recurrent stricture formation, extending the functional lifespan of the stent. Another key advancement is the development of biodegradable stents, which gradually dissolve over time, making them ideal for treating benign conditions without the need for removal procedures. Improvements in stent delivery systems have also contributed to the increased precision and safety of stent placement. Modern delivery systems are equipped with features such as controlled release mechanisms, enhanced radiopacity for better visualization, and preloaded guidewires, enabling endoscopists to deploy stents more accurately even in challenging anatomies. These technological strides are transforming esophageal stents into highly sophisticated devices that address a broader range of esophageal disorders with fewer complications.

How Are Shifting Patient Demographics and Treatment Approaches Impacting the Esophageal Stent Market?

The esophageal stent market is evolving rapidly, driven by changes in patient demographics, rising prevalence of esophageal cancers, and shifts in treatment paradigms. The global increase in esophageal cancer cases, especially adenocarcinoma linked to gastroesophageal reflux disease (GERD) and obesity, has led to a heightened demand for effective palliative solutions like esophageal stents. An aging population, which is more susceptible to both malignant and benign esophageal conditions, has further fueled the need for long-term management options that can ensure nutritional intake and reduce dysphagia. This demographic shift has prompted healthcare providers to prioritize interventions that enhance the quality of life, making esophageal stenting a preferred choice for palliative care in inoperable cancer cases. Simultaneously, changes in treatment approaches are also influencing the market. For instance, there is an increasing preference for endoscopic stenting over more invasive surgical procedures due to the reduced risk of complications, shorter recovery times, and lower costs associated with endoscopic techniques. This has expanded the use of esophageal stents in not only malignant cases but also in treating benign strictures, refractory esophageal varices, and postoperative anastomotic leaks. Moreover, patient-centric care models are shaping product development, with a growing emphasis on stents that offer ease of insertion, better patient tolerance, and minimal post-procedure complications. This shift has led to the design of stents with improved anchorage, softer materials to reduce ulceration, and innovative anti-migration features that ensure optimal positioning. The increasing adoption of minimally invasive stenting procedures in emerging markets is also driving growth, as these regions experience rising healthcare investment and a growing awareness of advanced treatment options for esophageal conditions.

What Are the Key Growth Drivers in the Esophageal Stent Market?

The growth in the esophageal stent market is driven by several critical factors, including the rising incidence of esophageal cancer, advancements in stent technology, and the increasing adoption of minimally invasive treatments. One of the primary drivers is the global surge in esophageal cancer cases, particularly in developed countries, where lifestyle factors such as smoking, heavy alcohol use, and chronic acid reflux have contributed to a higher incidence of adenocarcinoma. This has led to an increased need for palliative care options that can alleviate dysphagia and enhance the quality of life for patients in advanced stages of cancer. Technological innovations, such as the development of self-expanding metal stents with enhanced flexibility and anti-migration properties, are also playing a pivotal role in expanding the clinical applications of esophageal stents. The incorporation of drug-eluting and biodegradable stents is providing new therapeutic options for managing benign conditions and preventing restenosis, further boosting market demand. Another significant growth driver is the widespread adoption of endoscopic procedures, which are less invasive than traditional surgery and associated with faster recovery times. As more healthcare providers embrace endoscopic stenting as the standard approach for treating both malignant and benign esophageal obstructions, the demand for advanced stents has surged. Furthermore, the expansion of healthcare infrastructure in emerging markets, along with increased healthcare expenditure and the rising prevalence of esophageal disorders, is creating new opportunities for market growth. The trend toward value-based healthcare is also driving interest in stents that offer improved long-term outcomes and reduced complication rates, making them a cost-effective solution in the management of esophageal diseases. These diverse growth drivers are transforming the esophageal stent market, positioning it for sustained expansion as healthcare systems worldwide continue to prioritize minimally invasive solutions for esophageal pathologies.

SCOPE OF STUDY:

The report analyzes the Esophageal Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Andratec GmbH
• Boston Scientific Corporation
• BVM Medical Limited
• C. R. Bard, Inc.
• Cook Group Incorporated
• Ella - CS, s.r.o.
• Endo-Flex GmbH
• M.I.Tech
• Merit Medical Systems, Inc.
• Taewoong Medical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Esophageal Stents - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Esophageal Cancers Throws the Spotlight on Stenting as a Palliative Solution
  • Growing Adoption of Minimally Invasive Treatments Propels Demand for Esophageal Stents
  • Here's How Technological Advancements in Stent Design Strengthen the Business Case for Adoption
  • Expanding Use of Self-Expanding Metal Stents Drives Market Growth with Enhanced Clinical Outcomes
  • Increasing Preference for Endoscopic Procedures Generates Demand for Esophageal Stenting
  • Here's the Story: Rising Geriatric Population Sustains Growth in Demand for Dysphagia Management
  • Innovations in Anti-Migration and Anti-Reflux Features Expand the Addressable Market
  • Growing Incidence of Esophageal Strictures Spurs Demand for Safe and Effective Stent Solutions
  • Trend Toward Bioabsorbable Stents Expands Market Opportunity in Short-Term Therapeutic Applications
  • Here's How Increasing Use in Benign Conditions Generates New Market Opportunities
  • Rising Incidence of Gastroesophageal Reflux Disease (GERD) Creates Niche Growth Potential
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Esophageal Stents Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: USA 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: Canada 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• JAPAN
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: Japan 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• CHINA
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: China 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• EUROPE
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: Europe 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• FRANCE
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: France 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• GERMANY
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: Germany 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: Italy 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: UK 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 44: Spain Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Spain Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: Spain 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 47: Russia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Russia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: Russia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: Rest of Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: Asia-Pacific 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 59: Australia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Australia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Australia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• INDIA
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 62: India Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: India Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: India 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 65: South Korea Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: South Korea Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: South Korea 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Rest of Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 71: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 72: Latin America Historic Review for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Latin America 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 74: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 77: Argentina Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Argentina Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Argentina 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 80: Brazil Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Brazil Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Brazil 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 83: Mexico Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Mexico Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: Mexico 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Rest of Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: Rest of Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 89: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 90: Middle East Historic Review for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: Middle East 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 92: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 95: Iran Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Iran Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Iran 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 98: Israel Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Israel Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Israel 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Saudi Arabia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Saudi Arabia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 104: UAE Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UAE Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: UAE 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Rest of Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Rest of Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
• AFRICA
  • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 110: Africa Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Africa Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: Africa 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION